Client support: Phone: (+357) 22314160

FX & CFD trading involves significant risk


Show news:

17.02.2011 07:25

Stocks: Wednesday's review

Japan’s Nikkei 225 Stock Average gained for an eighth day, extending its longest winning streak in 18 months, after the yen weakened and as brokerages raised investment recommendations on some companies.

Sumitomo Mitsui Financial Group Inc., Japan’s 2nd-largest bank by market value, climbed 2.3 percent after Nomura Holdings Inc. said the nation’s economy will rebound sooner than expected. Sony Corp., Japan’s biggest exporter of consumer electronics, advanced 2.6 percent. Toshiba Corp., a nuclear power-plant maker, and Asahi Glass Co. advanced at least 2.2 percent after brokerages increased their ratings on the companies.

European stocks rose for a fourth day, pushing the Stoxx Europe 600 Index to a 2 1/2-year high, as earnings from Heineken NV and Societe Generale SA beat estimates and U.S. housing starts topped forecasts.
Heineken, the world’s third-largest brewer, and Societe Generale, France’s second-biggest lender, rallied more than 3 percent. Sanofi-Aventis SA climbed 3.5 percent after agreeing to buy Genzyme Corp. for at least $20.1 billion. Clariant AG sank the most in eight years after saying it will acquire Sued-Chemie AG in a deal valued at 2 billion euros ($2.7 billion).

U.S. stocks gained Wednesday, propelled by a $20 billion merger in the pharmaceutical sector and a batch of solid corporate earnings.
The S&P 500 (SPX) added 8 points, or 0.6%, to 1,336.40, more than doubling its financial meltdown low of 666.79 on March 6, 2009.
Family Dollar (FDO, Fortune 500) rallied 10% after the discount retailer said it received an unsolicited offer from Nelson Peltz's Trian Group, making it the biggest gainer on the S&P 500.
The Nasdaq (COMP) rose 24 points, or 0.9%, led by a 13% jump in shares of Dell (DELL, Fortune 500), which delivered a stellar fourth-quarter profit. Comcast (CMCSA, Fortune 500) was also a strong performer on the tech-heavy index, with the cable TV provider jumping 5% after reporting better-than-expected quarterly results.
Investors were also cheering the latest big M&A deal. French drugmaker Sanofi-aventis agreed to buy Genzyme, a Massachusetts-based biotech company, for $20.1 billion in cash. The deal was announced before the opening bell. Sanofi (SNY) shares rose 1%, while Genzyme (GENZ, Fortune 500)'s stock increased 1.3%.
Economy: A government report showed the number of housing starts rose more than expected in January, while permits for new construction were weaker than forecast.
Housing starts rose 14% to an annual rate of 596,000 units last month, while building permits, considered a leading indicator of activity, fell 10% to an annual rate of 562,000 in January.
Minutes from the most recent meeting of the Federal Reserve released Wednesday showed that policymakers anticipate a bigger bump in economic growth for 2011 than they thought just a few months ago. But the Fed said the acceleration in growth will mainly be limited to the short term, as growth estimates for 2012 and 2013 were only slightly adjusted.

17.02.2011 07:21

Tech on USD/JPY

Market Focus

  • U.S.: Industrial Production (MoM), September 0.1% (forecast 0.2%)
  • Britain can't get full single market access with free movement concessions - Merkel
  • Earnings Season in U.S.. Major Reports of the Week
  • New Zealand CPI, 3Q: 0.2% q/q (forecast 0%), 0.2% y/y (forecast 0.1%)
October 2016
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002


All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.

To maximize our visitors browsing experience TeleTrade uses cookies in our web services. By continuing to browse this site you agree to our use of cookies. If you disagree, you may change your browser settings at any time. Read more

  • © 2011-2016 TeleTrade-DJ International Consulting Ltd

    TeleTrade-DJ International Consulting Ltd is registered as a Cyprus Investment Firm (CIF) under registration number HE272810 and licensed by the Cyprus Securities and Exchange Commission (CySEC) under license number 158/11.

    The company operates in accordance with Markets in Financial Instruments Directive (MiFID).

  • The information on this website is for informational purposes only. All the services and information provided have been obtained from sources deemed to be reliable. TeleTrade-DJ International Consulting Ltd ("TeleTrade") and/or any third-party information providers provide the services and information without warranty of any kind. By using this information and services you agree that under no circumstances shall TeleTrade have any liability to any person or entity for any loss or damage in whole or part caused by reliance on such information and services.

  • TeleTrade cooperates with SafeCharge Limited, which is an electronic money institution authorized and regulated by the Central Bank of Cyprus and is a principal member of MasterCard Europe and Visa Europe. We also cooperate with Moneybookers and Neteller, which offer electronic e-wallet services authorized and regulated by the Financial Conduct Authority.

    Please read our full Terms of Use.

  • To maximize our visitors browsing experience TeleTrade uses cookies in our web services. By continuing to browse this site you agree to our use of cookies. If you disagree, you may change your browser settings at any time. Read more

    TeleTrade-DJ International Consulting Ltd currently does not provide its services to residents or nationals of the USA, and also doesn't provide retail Forex and CFD accounts to residents or nationals of Belgium.

Служба технической поддержки:

  • Онлайн-консультация
  • Заказать звонок
  • Написать письмо
Connect with Us
Share on
social networks
Request a callback
Top Page